Meghan Scanlon Boston Scientific Corp (BSX) insider trading activity

BSX Quotes by TradingView

Meghan Scanlon is SVP,Pres,Urology Pelvic Health of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 24,461 shares of BSX, which is worth approximately $2.24 Million. The most recent transaction as insider was on Feb 21, 2021, when has been sold 779 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.5K
0% 3M change
0% 12M change
Total Value Held $2.24 Million

Meghan Scanlon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 21 2021
BUY
Exercise of conversion of derivative security
-
779 Added 4.92%
15,057 Common Stock
Feb 18 2021
SELL
Payment of exercise price or tax liability
$13,957 $37.52 p/Share
372 Reduced 2.54%
14,278 Common Stock
Feb 18 2021
BUY
Exercise of conversion of derivative security
-
1,111 Added 7.05%
14,650 Common Stock
Feb 15 2021
SELL
Payment of exercise price or tax liability
$14,895 $38.39 p/Share
388 Reduced 2.79%
13,539 Common Stock
Feb 15 2021
BUY
Exercise of conversion of derivative security
-
1,107 Added 7.36%
13,927 Common Stock

Also insider at

FNA
Paragon 28, Inc. Healthcare
MS

Meghan Scanlon

SVP,Pres,Urology Pelvic Health
Marlborough, MA

Track Institutional and Insider Activities on BSX

Follow BOSTON SCIENTIFIC CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

News

Receive news related to BOSTON SCIENTIFIC CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BSX